Adaptive Biotechnologies Corporation (ADPT)
NASDAQ·Healthcare·Biotechnology
$14.00
-1.48%
Mkt Cap $2.19B
Analyst Ratings
Buy
5
Hold
1
Sell
0
Price Target (11 analysts)
$21.25
Range $21.00 – $22.00
Implied Upside
+51.8%
Consensus $21.25 vs current $14.00